339 related articles for article (PubMed ID: 21696175)
1. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
2. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
3. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of polymethoxylated 4-heteroarylcoumarins as tubulin assembly inhibitor.
Ganina OG; Daras E; Bourgarel-Rey V; Peyrot V; Andresyuk AN; Finet JP; Fedorov AY; Beletskaya IP; Combes S
Bioorg Med Chem; 2008 Oct; 16(19):8806-12. PubMed ID: 18805012
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
[TBL] [Abstract][Full Text] [Related]
6. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
O'Boyle NM; Carr M; Greene LM; Bergin O; Nathwani SM; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
J Med Chem; 2010 Dec; 53(24):8569-84. PubMed ID: 21080725
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of benzils related to combretastatin A-4.
Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
10. A concise synthesis of pyrazole analogues of combretastatin A1 as potent anti-tubulin agents.
Zaninetti R; Cortese SV; Aprile S; Massarotti A; Canonico PL; Sorba G; Grosa G; Genazzani AA; Pirali T
ChemMedChem; 2013 Apr; 8(4):633-43. PubMed ID: 23436706
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
12. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
13. A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors.
Barnes NG; Parker AW; Ahmed Mal Ullah AA; Ragazzon PA; Hadfield JA
Bioorg Med Chem; 2020 Oct; 28(19):115684. PubMed ID: 32912434
[TBL] [Abstract][Full Text] [Related]
14. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
[TBL] [Abstract][Full Text] [Related]
15. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
[TBL] [Abstract][Full Text] [Related]
17. A new family of quinoline and quinoxaline analogues of combretastatins.
Pérez-Melero C; Maya AB; del Rey B; Peláez R; Caballero E; Medarde M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3771-4. PubMed ID: 15203159
[TBL] [Abstract][Full Text] [Related]
18. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]